These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1718970)
1. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells. Ziegler A; Knesel J; Fabbro D; Nagamine Y J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970 [TBL] [Abstract][Full Text] [Related]
2. Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism. Ziegler A; Hagmann J; Kiefer B; Nagamine Y J Biol Chem; 1990 Dec; 265(34):21194-201. PubMed ID: 1701176 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3',5'-monophosphate. Bergonzelli GE; Kruithof EK; Medcalf RL Endocrinology; 1992 Sep; 131(3):1467-72. PubMed ID: 1354603 [TBL] [Abstract][Full Text] [Related]
4. hsp70 mRNA accumulates in LLC-PK1 pig kidney cells treated with calcitonin but not with 8-bromo-cyclic AMP. Andrus L; Altus MS; Pearson D; Grattan M; Nagamine Y J Biol Chem; 1988 May; 263(13):6183-7. PubMed ID: 3360780 [TBL] [Abstract][Full Text] [Related]
5. Okadaic acid induction of the urokinase-type plasminogen activator gene occurs independently of cAMP-dependent protein kinase and protein kinase C and is sensitive to protein synthesis inhibition. Nagamine Y; Ziegler A EMBO J; 1991 Jan; 10(1):117-22. PubMed ID: 1846595 [TBL] [Abstract][Full Text] [Related]
6. Dependence of urokinase-type-plasminogen-activator induction on cyclic AMP-dependent protein kinase activation in LLC-PK1 cells. Jans DA; Resink TJ; Hemmings BA Biochem J; 1987 Apr; 243(2):413-8. PubMed ID: 2820380 [TBL] [Abstract][Full Text] [Related]
7. A new genetic approach for studying hormonal regulation of urokinase-type plasminogen activator gene expression in LLC-PK1 cells. Hofstetter P; Kikinis Z; Altus MS; Pearson D; Nagamine Y Mol Cell Biol; 1987 Dec; 7(12):4535-41. PubMed ID: 2830499 [TBL] [Abstract][Full Text] [Related]
8. Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene. Marksitzer R; Stief A; Menoud PA; Nagamine Y J Biol Chem; 1995 Sep; 270(37):21833-8. PubMed ID: 7665606 [TBL] [Abstract][Full Text] [Related]
9. Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK1 cells down-regulated for protein kinase C--correlation with cytoplasmic heterogeneous nuclear ribonucleoprotein C. Nanbu R; Montero L; D'Orazio D; Nagamine Y Eur J Biochem; 1997 Jul; 247(1):169-74. PubMed ID: 9249023 [TBL] [Abstract][Full Text] [Related]
10. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression. Botteri FM; Ballmer-Hofer K; Rajput B; Nagamine Y J Biol Chem; 1990 Aug; 265(22):13327-34. PubMed ID: 1695907 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. Tamir A; Granot Y; Isakov N J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733 [TBL] [Abstract][Full Text] [Related]
12. Staurosporine stimulates expression of the urokinase-type (u-PA) plasminogen activator in LLC-PK1 cells. Dierks-Ventling C; Knesel J; Nagamine Y; Hemmings BA; Pehling G; Fischer F; Fabbro D Int J Cancer; 1989 Nov; 44(5):865-70. PubMed ID: 2583867 [TBL] [Abstract][Full Text] [Related]
13. Regulation of gonadotropin-releasing hormone by protein kinase-A and -C in immortalized hypothalamic neurons. Wetsel WC; Eraly SA; Whyte DB; Mellon PL Endocrinology; 1993 Jun; 132(6):2360-70. PubMed ID: 8504741 [TBL] [Abstract][Full Text] [Related]
14. Induction and desensitization of plasminogen activator gene expression by tumor promoters. Degen JL; Estensen RD; Nagamine Y; Reich E J Biol Chem; 1985 Oct; 260(23):12426-33. PubMed ID: 3862668 [TBL] [Abstract][Full Text] [Related]
15. Retinoic acid priming potentiates the induction of urokinase-type plasminogen activator by cyclic adenosine monophosphate in mouse mammary carcinoma cells. Mira-y-Lopez R J Cell Physiol; 1991 Apr; 147(1):46-54. PubMed ID: 1645361 [TBL] [Abstract][Full Text] [Related]
16. Pathway of urokinase-type plasminogen activator induction in the T47D and LLC-PK1 cell lines. Jans DA; Dierks-Ventling C; Hemmings BA Exp Cell Res; 1987 Sep; 172(1):76-83. PubMed ID: 3653259 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of cAMP-mediated gene induction: examination of renal epithelial cell mutants affected in the catalytic subunit of the cAMP-dependent protein kinase. Pearson D; Nigg EA; Nagamine Y; Jans DA; Hemmings BA Exp Cell Res; 1991 Jan; 192(1):315-8. PubMed ID: 1898592 [TBL] [Abstract][Full Text] [Related]
18. The expression of 80K/MARCKS, a major substrate of protein kinase C (PKC), is down-regulated through both PKC-dependent and -independent pathways. Effects of bombesin, platelet-derived growth factor, and cAMP. Brooks SF; Herget T; Broad S; Rozengurt E J Biol Chem; 1992 Jul; 267(20):14212-8. PubMed ID: 1378435 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase activity-dependent inhibition of urokinase-type plasminogen activator gene transcription by cyclic AMP in human pre-B lymphoma cell line RC-K8. Shinbo M; Niiya K; al-Mokdad M; Hayakawa Y; Hiraga K; Fujimaki M; Sakuragawa N Biochim Biophys Acta; 1995 Sep; 1268(3):293-9. PubMed ID: 7548228 [TBL] [Abstract][Full Text] [Related]
20. Activation of cAMP-dependent protein kinase alters the chromatin structure of the urokinase-type plasminogen activator gene promoter. Lee JS; Catanzariti L; Hemmings BA; Kiefer B; Nagamine Y Nucleic Acids Res; 1994 Feb; 22(4):569-75. PubMed ID: 8127705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]